Current disease status-Recurrent cancer - Page 15 of 19 Posts on Medivizor
Navigation Menu

Current disease status-Recurrent cancer Posts on Medivizor

More radiation in shorter treatments

More radiation in shorter treatments

Posted by on Nov 30, 2013 in Prostate cancer | 0 comments

In a nutshell In this study researchers compared conventional radiation therapy to hypofractionated radiotherapy. Some background Radiation therapy is a treatment used to kill cancer cells and is commonly used in the treatment of prostate cancer patients. Recent research suggests that increasing radiation doses above those used in conventional...

Read More

What is the role of conversion chemotherapy?

What is the role of conversion chemotherapy?

Posted by on Nov 28, 2013 in Colorectal cancer | 0 comments

In a nutshell This study assessed the survival rates and characteristics of metastatic colorectal cancer (CRC) patients with liver-limited disease (LLD) who underwent conversion chemotherapy. Some background Colorectal cancer patients may develop metastases (spread of the cancer to other distant organs and tissues of the body) and the liver is one...

Read More

Is chemo-radiotherapy beneficial?

Is chemo-radiotherapy beneficial?

Posted by on Nov 22, 2013 in Lung cancer | 0 comments

In a nutshell This study evaluated the safety and efficacy of chemotherapy (CT) given concurrently with 3-dimensional conformal radiotherapy (3D-CRT) for the treatment of patients with metastatic non-small cell lung cancer or mNSCLC (lung cancer that has spread to distant organs of the body).  Some background Chemotherapy (CT) uses drugs that...

Read More

Sorafenib; a new potential treatment for lung cancer

Sorafenib; a new potential treatment for lung cancer

Posted by on Nov 19, 2013 in Lung cancer | 0 comments

In a nutshell This study investigated the use of a sorafenib (Nexavar) for the treatment of non-small cell lung cancer. Some background Approximately 85% of lung cancers are classified as non-small cell lung cancers (NSCLC). NSCLC spreads easily throughout the lung tissue forming small malignant tumors. Although treatments have advanced in recent...

Read More

Trials in mTOR inhibition

Trials in mTOR inhibition

Posted by on Nov 12, 2013 in Breast cancer | 0 comments

In a nutshell This article reviewed the significance of the mTOR protein in breast cancer patients and its potential as a target for cancer treatments. Some background Current cancer treatments are often based on specific molecular activities of the cancer important for tumor growth and spread. For example, since the hormone estrogen...

Read More

Current therapy and ongoing advances

Current therapy and ongoing advances

Posted by on Nov 2, 2013 in Lung cancer | 0 comments

In a nutshell This review discusses current therapy as well as ongoing advances in the treatment of non small-cell lung cancer. Some background Many advances have been made in recent years in the treatment of non small-cell lung cancer (NSCLC). New technologies used in radiation therapy are allowing for a more targeted and precise delivery of...

Read More

Can physical activity improve survival?

Can physical activity improve survival?

Posted by on Oct 18, 2013 in Colorectal cancer | 0 comments

In a nutshell This trial investigated the association between physical activity and the risk of recurrence (return of the cancer) and survival in patients with colon cancer (cancer of the large intestine). Some background The treatments of colon cancer have improved significantly over the years. However, many patients still have high risks for...

Read More

Promising treatment for carcinoid tumors

Promising treatment for carcinoid tumors

Posted by on Oct 14, 2013 in Lung cancer | 0 comments

In a nutshell This article reviewed the medical literature about the mTOR protein and the potential treatment of carcinoid tumors using mTOR inhibitors.   Some background mTOR is a protein responsible for cell growth, proliferation and cell survival. A dysfunctional mTOR protein has been found in many types of cancer. Among these types...

Read More